Royalty Pharma (RPRX) EBT Margin Growth (1y) (2020 - 2026)
Powered by 
Analysis
Royalty Pharma (RPRX) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.91 Bn | 45.24 Bn | 4.68 Bn | 2,683.00 |
| 2 | Royalty Pharma | 36.78 Bn | 38.89 Bn | - | -392.00 |
| 3 | Royal Gold | 22.19 Bn | 22.06 Bn | 390.45 Mn | -256.00 |
| 4 | OR Royalties | 6.98 Bn | 6.91 Bn | 82.22 Mn | 1,074.00 |
| 5 | Encore Capital | 2.06 Bn | 1.88 Bn | 455.04 Mn | -80.00 |
| 6 | Atlanticus Holdings | 1.41 Bn | 853.17 Mn | 686.46 Mn | -132.00 |
| 7 | Jefferson Capital | 1.23 Bn | 1.21 Bn | - | -1,050.00 |
| 8 | Upbound | 1.11 Bn | 1.00 Bn | 594.84 Mn | 54.00 |
| 9 | Lufax Holding | 1.08 Bn | -1.19 Bn | - | -1,504.00 |
| 10 | Metalla Royalty & Streaming | 957.79 Mn | 946.72 Mn | 4.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -392.00 |
| Mar 31, 2026 | -219.00 |
| Dec 31, 2025 | 90.00 |
| Sep 30, 2025 | -6,989.00 |
| Jun 30, 2025 | -2,017.00 |
| Mar 31, 2025 | 7,720.00 |
| Dec 31, 2024 | -6,406.00 |
| Sep 30, 2024 | 12,003.00 |
| Jun 30, 2024 | -2,910.00 |
| Mar 31, 2024 | -7,518.00 |
| Dec 31, 2023 | 22,821.00 |
| Sep 30, 2023 | -1,567.00 |
| Jun 30, 2023 | -2,644.00 |
| Mar 31, 2023 | 5,164.00 |
| Dec 31, 2022 | -11,715.00 |
| Sep 30, 2022 | 57.00 |
| Jun 30, 2022 | -5,365.00 |
| Mar 31, 2022 | -496.00 |
| Dec 31, 2021 | -5,476.00 |
| Sep 30, 2021 | -7,808.00 |